As per Future Market insights (FMI), the global market for cat food is anticipated to surpass a valuation of US$ 65.21 Bn by 2031 in comparison to the valuation of US$ 40.78 Bn registered in 2021, expanding at a CAGR of 4.8% over the forecast period 2021-2031. The cat adoption rate is phenomenally increasing, especially …
Author Archives: Editor AN
Caramel Food Colors Market | Latest Scenario On Innovation, Revolutionary Opportunities & Top Consumers 2031
According to Future Market Insights, the market for caramel food colours is predicted to be worth US$1,65,208.1 Thousand in 2021. (FMI). Increasing at a CAGR of 9.5% from 2021 to 2031, the total market value is anticipated to reach US$ 4,09,088.4 Thousand. Growing preference for foods that are not only appealing but also nutritious and …
Insulin Delivery Pens Market to reach a valuation of US$ 48.6 Billion by the end of 2032 | FMI
[Report of 276 Pages] The market for insulin delivery pens is anticipated to reach US$ 22.4 billion by the end of 2022 and continue to grow at a CAGR of 8.0% to reach US$ 48.6 billion by the end of 2032. In 2021, smart insulin pens held a market share of approximately 34.6%, according to a recent …
Rosai-Dorfman Disease (RDD) Therapeutics Market value of US$ 431 Million in 2023 | Exclusive Report by FMI
During the forecast period 2023 to 2033, the Rosai-Dorfman Disease (RDD) Therapeutics market is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Rosai-Dorfman Disease (RDD) Therapeutics is expected to rise up to a market valuation of US$ 839.95 Million. The global RDD therapeutics …
Anti Neurofilament L Antibody Market is likely to rise from US$ 145 Billion in 2022 to US$ 457 Billion by 2032
[Report of 250 Pages] From 2022 to 2032, the anti-neurofilament L antibody market is projected to expand incrementally at a CAGR of 11%. By 2032, the anti-neurofilament L antibody market is expected to have grown from US$ 145 billion to US$ 457 billion. Neurofilament is a type of filament that is required for the cytoskeleton of a …
Progressive Multifocal Leukoencephalopathy Treatment Market is expected to grow with a 3% CAGR from 2023 to 2033
The global progressive multifocal leukoencephalopathy treatment market is expected to garner a market value of US$ 1,320 million in 2023 and is expected to accumulate a market value of US$ 1,773.97 million by registering a CAGR of 3% in the forecast period 2023 to 2033. The market for progressive multifocal leukoencephalopathy treatment registered a CAGR of 2% …
Spinal Osteosynthesis Units Market to grow at a CAGR of around 4.8% over the assessment period 2022 to 2032
[Report of 250 Pages] Around US$ 2.8 billion was spent on spinal osteosynthesis units globally in 2021. The market is anticipated to grow at a steady CAGR of 4.8% between 2022 and 2032, surpassing US$ 3.9 Billion by that year due to the rapid increase in spinal surgeries and rising incidence of spinal conditions like lumbar spondylosis, …
Mobility Aids And Transportation Equipment Market is projected to surpass $6318 million by 2023 | FMI Study
[Report of 250 Pages] By 2023, the market for transportation and mobility aids is anticipated to reach more than $6318 million, growing at a projected CAGR of more than 6.1% from 2018 to 2023. Future Market Insight’s (FMI’s) latest study published on the Mobility Aids And Transportation Equipment market provide insights into key factors uplifting the sales …
Systemic Lupus Erythematous SLE Drugs Market is projected to record a CAGR of 5% during the forecast period 2022 to 2032
[250 Pages Report] Global systemic lupus erythematous drugs market growth is fast in North American region and is estimated to project remarkable CAGR growth throughout forecast period. In North America, the SLE is more prevalent among Hispanics, Asians, and Native Americans according to Centers for Disease Control and Prevention (CDC). The second largest and fastest growing global …
Legionnaire Disease Testing Market is projected to register a CAGR of 9% during the forecast period 2022 to 2032
The legionnaire disease testing market is projected to register a CAGR of 9% during the forecast period, up from US$ 292 Mn in 2022 to reach a valuation of US$ 819.5 Mn by 2032. A severe form of pneumonia infection is known as legionnaire disease which causes lung inflammation. The bacteria are known as legionella cause legionnaire disease. The …